Journals / Türk Toraks Dergisi / 2011 / Cilt: 12 - Sayı: 1

The incidence of sick euthyroid syndrome in chronic obstructive pulmonary disease

Kronik obstrüktif akciğer hastalığında hasta ötiroid sendromu sıklığı

Pages
1–4
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, we determined that SES is significantly higher in acute than stabile cases in COPD (p<0.001).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Sick euthyroid syndrome (SES) is defined as abnormal thyroid hormone levels without any thyroid diseasei which is seen during the progression of chronic or severe diseases.
📊
Key Findings & Data:The common feature of this disorder is a low level of free triiodothyronine (fT3), with generally normal blood free thyroxine (fT4) levels and either normal or slightly suppressed thyroidstimulating hormone (TSH).
💡
Conclusion & Impact:Conclusion: In conclusion, we determined that SES is significantly higher in acute than stabile cases in COPD (p<0.001).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Sick euthyroid syndrome (SES) is defined as abnormal thyroid hormone levels without any thyroid diseasei which is seen during the progression of chronic or severe diseases. The common feature of this disorder is a low level of free triiodothyronine (fT3), with generally normal blood free thyroxine (fT4) levels and either normal or slightly suppressed thyroidstimulating hormone (TSH). Material and Method: We examined the incidence of SES in COPD patients either in a stable state or acute exacerbation. 45 cases, who had previously been diagnosed as COPD in our clinic, with severe or modarate disease, were included in the study. Cases were grouped according to the state of the disease; stable or in acute exacerbation. fT3, fT4, TSH levels and spirometry values in all cases and arterial blood gas analyses in cases with acute exacerbation were recorded. Results: Of the 45 cases with COPD (M/F:43/2) aged between 43 to 80 (61.6±9.9) years, 25 were in stable state and 20 cases were in acute exacerbation. Thyroid hormone levels in cases with acute exacerbation were fT3: 2.32±0.53 pg/ml, fT4:1.17±1.14 ng/dl, TSH:0.69±0.59, where the levels were fT3: 2.99±0.43 pg/ml, fT4: 0.79±0.11 ng/dl, TSH: 1.22±0.77 in stable cases. The fT3 level in the group with acute exacerbation was significantly lower than the cases in the stable state (p<0.001). SES was seen in 70% (14/20) percent of cases with acute exacerbation and 8% (2/25) of cases in the stable state. Conclusion: In conclusion, we determined that SES is significantly higher in acute than stabile cases in COPD (p<0.001).

Özet

Amaç: Kronik ve ciddi hastalıklar seyrinde ortaya çıkabilen tiroid hastalığı olmaksızın tiroid hormon düzeyindeki değişiklikler hasta ötiroid sendromu (HÖS) olarak tanımlanmaktadır. Bu hastalık bulguları genellikle normal sınırlardaki serbest tiroiodotironin (fT4) ile azalmış serbest tiroksin (fT3) düzeyi ve normal ya da hafif baskılanmış tirotropin (TSH) değerleridir. Gereç ve Yöntem: Çalışmamızda kronik obstruktif akciğer hastalığında (KOAH) stabil ve akut ataktaki olgularda tiroid hormon düzeyleri incelenerek HÖS oranı araştırıldı. Çalışmaya kliniğimizde daha önceden KOAH tanısı konulan orta-ağır 45 olgu alındı. Olgular akut atak ve stabil olmak üzere iki gruba ayrıldı. Tüm olgularda kan fT3, fT4, TSH değerleri, spirometri, akut atak nedeni ile hastaneye yatışı yapılan olgularda arter kan gazı değerleri kaydedildi. Bulgular: Yaş ortalaması 61.6±9.9 (43-80) yıl olan 45 olgunun (E/K: 43/2) 25’i stabil, diğer 20 olgu ise akut ataktaki KOAH olgularından oluşmakta idi. Akut ataktaki grupta fT3: 2.32±0.53 pg/ml, fT4: 1.17±1.11 ng/dl, TSH: 0.69±0.59 iken stabil olgularda bu değerler fT3: 2.99±0.43 pg/ml, fT4: 0.79±0.14 ng/dl, TSH: 1.22±0.77 saptandı. Akut ataktaki grupta fT3 değeri stabil KOAH grubuna göre anlamlı derecede düşük bulundu (p=0.0001). KOAH akut ataktaki olgularda HÖS %70 (14/20), stabil grupta %8 (2/25) sıklıkta görüldü. Sonuç: Sonuç olarak çalışmamızda akut ataktaki KOAH olgularında stabil olanlara göre HÖS oranı oldukça yüksek bulunmuştur (p< 0.001).

🔖

Cite This Article

KANMAZ, D., YENTÜRK, E., YILMAZ, B., ALKAN, N., RTUNCAY, E. (2011). The incidence of sick euthyroid syndrome in chronic obstructive pulmonary disease. Türk Toraks Dergisi, Cilt: 12 - Sayı: 1, 1–4. https://ajindex.com/articles/329622

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kelly GS. Peripheral metabolism of thyroid hormones: a review. Altern Med Rev 2000; 5: 306-33
  2. American Thoracic Society. Definitions; epidemiology, pathophysiology, diagnosis and staging. Am J Respir Care Med 1995; 152: 78-121
  3. Chopra IJ. Euthyroid sick syndrome: Is it a misnomer? J Clin Endocrinol Metab 1997; 82: 329-34
  4. Goichot B, Sapin R, Schlinger JL. Euthyroid sick syndrome: recent physiopathologic findings. Rev Med Interne 1998; 19: 640-8
  5. Bolen A, Platvoet-ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum T3 in nonthyroidal illness. J Clin Endoc 1993; 77: 1695-9
  6. Wu WI, Schwindinger WF, Aparicio LF, Levine MA. KOAH akut atakta hasta ötiroid sendromu sıklığı. Solunum 2004; 6: 14-7
  7. Seyhan EC, Çetinkaya E, Altın S. ve ark. KOAH atağına bağlı solunum yetmezliği saptanan olgularda hasta ötiroid sendrom sıklığı. Akciğer 2006; 12: 73-8
  8. Şahin İA, Erginel S, Metintaş M. ve ark. Koah şiddetinin tiroid fonksiyon testleri üzerine etkisi. Osmangazi Tıp Dergisi 2005; 27: 69-73
  9. Karadag, Ozcan H, Karul AB, et al. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease. Respir Med 2007; 101: 1439-46
  10. Dimopoulou I, Ilias I, Mastorakos G, et al. Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism 2001; 50: 1397-401
  11. Bratel T, Wennlund A, Carlstrom K. Impact of hypoxamia on neuroendocrine function and catecholamine secretion in chronic obstructive lung disease. Effects of long-term oxygen treatment. Respir Med 2000; 94: 1221-8
  12. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 76-80
  13. Gow SM, Seth J, Beckett GJ, et al. Thyroid function and endocrine abnormalities in elderly patient with severe chronic obstructive lung disease. Thorax 1987; 42: 520-5.